Pharma & Healthcare
Global Atropine Sulfate for Injection Market Research Report 2026
- Feb 03, 26
- ID: 698495
- Pages: 128
- Figures: 133
- Views: 9
This report delivers a comprehensive overview of the global Atropine Sulfate for Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Atropine Sulfate for Injection. The Atropine Sulfate for Injection market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Atropine Sulfate for Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Atropine Sulfate for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
American Regent
Hikma Pharmaceuticals
Apotex
Amneal Pharmaceuticals
Accord Healthcare
China Res Double-Crane
Hebei Kaiwei Pharmaceutical
Hebei Tiancheng Pharmaceutical
Tai Yu Chemical & Pharmaceutical
Tianjin Jinyao Pharmaceutical
Sunflower Pharmaceutical
China Shineway Pharm
CSPC Ouyi Pharmaceutical
Suicheng Pharmaceutical
Chengdu Brilliant Pharmaceutical
Anhui Changjiang Pharmaceutical
Shanghai Harvest Pharmaceutical
Hubei Xinghua Pharmaceutical
Changzhou Pharmaceutical Factory
Segment by Type
0.5 mg/mL
1 mg/mL
5 mg/ml
Others
by Application
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Atropine Sulfate for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Atropine Sulfate for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
The report segments the global Atropine Sulfate for Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Atropine Sulfate for Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
American Regent
Hikma Pharmaceuticals
Apotex
Amneal Pharmaceuticals
Accord Healthcare
China Res Double-Crane
Hebei Kaiwei Pharmaceutical
Hebei Tiancheng Pharmaceutical
Tai Yu Chemical & Pharmaceutical
Tianjin Jinyao Pharmaceutical
Sunflower Pharmaceutical
China Shineway Pharm
CSPC Ouyi Pharmaceutical
Suicheng Pharmaceutical
Chengdu Brilliant Pharmaceutical
Anhui Changjiang Pharmaceutical
Shanghai Harvest Pharmaceutical
Hubei Xinghua Pharmaceutical
Changzhou Pharmaceutical Factory
Segment by Type
0.5 mg/mL
1 mg/mL
5 mg/ml
Others
by Application
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Atropine Sulfate for Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Atropine Sulfate for Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
1 Atropine Sulfate for Injection Market Overview
1.1 Product Definition
1.2 Atropine Sulfate for Injection by Type
1.2.1 Global Atropine Sulfate for Injection Market Value by Type: 2025 vs 2032
1.2.2 0.5 mg/mL
1.2.3 1 mg/mL
1.2.4 5 mg/ml
1.2.5 Others
1.3 Atropine Sulfate for Injection by Application
1.3.1 Global Atropine Sulfate for Injection Market Value by Application: 2025 vs 2032
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Atropine Sulfate for Injection Market Size Estimates and Forecasts
1.4.1 Global Atropine Sulfate for Injection Revenue 2021–2032
1.4.2 Global Atropine Sulfate for Injection Sales 2021–2032
1.4.3 Global Atropine Sulfate for Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Atropine Sulfate for Injection Market Competition by Manufacturers
2.1 Global Atropine Sulfate for Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Atropine Sulfate for Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Atropine Sulfate for Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Atropine Sulfate for Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Atropine Sulfate for Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Atropine Sulfate for Injection, Product Types and Applications
2.7 Global Key Manufacturers of Atropine Sulfate for Injection, Date of Entry into the Industry
2.8 Global Atropine Sulfate for Injection Market Competitive Situation and Trends
2.8.1 Global Atropine Sulfate for Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Atropine Sulfate for Injection Players Market Share by Revenue
2.8.3 Global Atropine Sulfate for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atropine Sulfate for Injection Market Scenario by Region
3.1 Global Atropine Sulfate for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Atropine Sulfate for Injection Sales by Region: 2021–2032
3.2.1 Global Atropine Sulfate for Injection Sales by Region: 2021–2026
3.2.2 Global Atropine Sulfate for Injection Sales by Region: 2027–2032
3.3 Global Atropine Sulfate for Injection Revenue by Region: 2021–2032
3.3.1 Global Atropine Sulfate for Injection Revenue by Region: 2021–2026
3.3.2 Global Atropine Sulfate for Injection Revenue by Region: 2027–2032
3.4 North America Atropine Sulfate for Injection Market Facts & Figures by Country
3.4.1 North America Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Atropine Sulfate for Injection Sales by Country (2021–2032)
3.4.3 North America Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atropine Sulfate for Injection Market Facts & Figures by Country
3.5.1 Europe Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Atropine Sulfate for Injection Sales by Country (2021–2032)
3.5.3 Europe Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atropine Sulfate for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Atropine Sulfate for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Atropine Sulfate for Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Atropine Sulfate for Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atropine Sulfate for Injection Market Facts & Figures by Country
3.7.1 Latin America Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Atropine Sulfate for Injection Sales by Country (2021–2032)
3.7.3 Latin America Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Atropine Sulfate for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Atropine Sulfate for Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atropine Sulfate for Injection Sales by Type (2021–2032)
4.1.1 Global Atropine Sulfate for Injection Sales by Type (2021–2026)
4.1.2 Global Atropine Sulfate for Injection Sales by Type (2027–2032)
4.1.3 Global Atropine Sulfate for Injection Sales Market Share by Type (2021–2032)
4.2 Global Atropine Sulfate for Injection Revenue by Type (2021–2032)
4.2.1 Global Atropine Sulfate for Injection Revenue by Type (2021–2026)
4.2.2 Global Atropine Sulfate for Injection Revenue by Type (2027–2032)
4.2.3 Global Atropine Sulfate for Injection Revenue Market Share by Type (2021–2032)
4.3 Global Atropine Sulfate for Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Atropine Sulfate for Injection Sales by Application (2021–2032)
5.1.1 Global Atropine Sulfate for Injection Sales by Application (2021–2026)
5.1.2 Global Atropine Sulfate for Injection Sales by Application (2027–2032)
5.1.3 Global Atropine Sulfate for Injection Sales Market Share by Application (2021–2032)
5.2 Global Atropine Sulfate for Injection Revenue by Application (2021–2032)
5.2.1 Global Atropine Sulfate for Injection Revenue by Application (2021–2026)
5.2.2 Global Atropine Sulfate for Injection Revenue by Application (2027–2032)
5.2.3 Global Atropine Sulfate for Injection Revenue Market Share by Application (2021–2032)
5.3 Global Atropine Sulfate for Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Atropine Sulfate for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 American Regent
6.2.1 American Regent Company Information
6.2.2 American Regent Description and Business Overview
6.2.3 American Regent Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 American Regent Atropine Sulfate for Injection Product Portfolio
6.2.5 American Regent Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Company Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hikma Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Apotex Atropine Sulfate for Injection Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Amneal Pharmaceuticals
6.5.1 Amneal Pharmaceuticals Company Information
6.5.2 Amneal Pharmaceuticals Description and Business Overview
6.5.3 Amneal Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Amneal Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
6.5.5 Amneal Pharmaceuticals Recent Developments/Updates
6.6 Accord Healthcare
6.6.1 Accord Healthcare Company Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Accord Healthcare Atropine Sulfate for Injection Product Portfolio
6.6.5 Accord Healthcare Recent Developments/Updates
6.7 China Res Double-Crane
6.7.1 China Res Double-Crane Company Information
6.7.2 China Res Double-Crane Description and Business Overview
6.7.3 China Res Double-Crane Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 China Res Double-Crane Atropine Sulfate for Injection Product Portfolio
6.7.5 China Res Double-Crane Recent Developments/Updates
6.8 Hebei Kaiwei Pharmaceutical
6.8.1 Hebei Kaiwei Pharmaceutical Company Information
6.8.2 Hebei Kaiwei Pharmaceutical Description and Business Overview
6.8.3 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.8.5 Hebei Kaiwei Pharmaceutical Recent Developments/Updates
6.9 Hebei Tiancheng Pharmaceutical
6.9.1 Hebei Tiancheng Pharmaceutical Company Information
6.9.2 Hebei Tiancheng Pharmaceutical Description and Business Overview
6.9.3 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.9.5 Hebei Tiancheng Pharmaceutical Recent Developments/Updates
6.10 Tai Yu Chemical & Pharmaceutical
6.10.1 Tai Yu Chemical & Pharmaceutical Company Information
6.10.2 Tai Yu Chemical & Pharmaceutical Description and Business Overview
6.10.3 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.10.5 Tai Yu Chemical & Pharmaceutical Recent Developments/Updates
6.11 Tianjin Jinyao Pharmaceutical
6.11.1 Tianjin Jinyao Pharmaceutical Company Information
6.11.2 Tianjin Jinyao Pharmaceutical Description and Business Overview
6.11.3 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.11.5 Tianjin Jinyao Pharmaceutical Recent Developments/Updates
6.12 Sunflower Pharmaceutical
6.12.1 Sunflower Pharmaceutical Company Information
6.12.2 Sunflower Pharmaceutical Description and Business Overview
6.12.3 Sunflower Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sunflower Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.12.5 Sunflower Pharmaceutical Recent Developments/Updates
6.13 China Shineway Pharm
6.13.1 China Shineway Pharm Company Information
6.13.2 China Shineway Pharm Description and Business Overview
6.13.3 China Shineway Pharm Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 China Shineway Pharm Atropine Sulfate for Injection Product Portfolio
6.13.5 China Shineway Pharm Recent Developments/Updates
6.14 CSPC Ouyi Pharmaceutical
6.14.1 CSPC Ouyi Pharmaceutical Company Information
6.14.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.14.3 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.14.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.15 Suicheng Pharmaceutical
6.15.1 Suicheng Pharmaceutical Company Information
6.15.2 Suicheng Pharmaceutical Description and Business Overview
6.15.3 Suicheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Suicheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.15.5 Suicheng Pharmaceutical Recent Developments/Updates
6.16 Chengdu Brilliant Pharmaceutical
6.16.1 Chengdu Brilliant Pharmaceutical Company Information
6.16.2 Chengdu Brilliant Pharmaceutical Description and Business Overview
6.16.3 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.16.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
6.17 Anhui Changjiang Pharmaceutical
6.17.1 Anhui Changjiang Pharmaceutical Company Information
6.17.2 Anhui Changjiang Pharmaceutical Description and Business Overview
6.17.3 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.17.5 Anhui Changjiang Pharmaceutical Recent Developments/Updates
6.18 Shanghai Harvest Pharmaceutical
6.18.1 Shanghai Harvest Pharmaceutical Company Information
6.18.2 Shanghai Harvest Pharmaceutical Description and Business Overview
6.18.3 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.18.5 Shanghai Harvest Pharmaceutical Recent Developments/Updates
6.19 Hubei Xinghua Pharmaceutical
6.19.1 Hubei Xinghua Pharmaceutical Company Information
6.19.2 Hubei Xinghua Pharmaceutical Description and Business Overview
6.19.3 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.19.5 Hubei Xinghua Pharmaceutical Recent Developments/Updates
6.20 Changzhou Pharmaceutical Factory
6.20.1 Changzhou Pharmaceutical Factory Company Information
6.20.2 Changzhou Pharmaceutical Factory Description and Business Overview
6.20.3 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Product Portfolio
6.20.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atropine Sulfate for Injection Industry Chain Analysis
7.2 Atropine Sulfate for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atropine Sulfate for Injection Production Mode & Process Analysis
7.4 Atropine Sulfate for Injection Sales and Marketing
7.4.1 Atropine Sulfate for Injection Sales Channels
7.4.2 Atropine Sulfate for Injection Distributors
7.5 Atropine Sulfate for Injection Customer Analysis
8 Atropine Sulfate for Injection Market Dynamics
8.1 Atropine Sulfate for Injection Industry Trends
8.2 Atropine Sulfate for Injection Market Drivers
8.3 Atropine Sulfate for Injection Market Challenges
8.4 Atropine Sulfate for Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Atropine Sulfate for Injection by Type
1.2.1 Global Atropine Sulfate for Injection Market Value by Type: 2025 vs 2032
1.2.2 0.5 mg/mL
1.2.3 1 mg/mL
1.2.4 5 mg/ml
1.2.5 Others
1.3 Atropine Sulfate for Injection by Application
1.3.1 Global Atropine Sulfate for Injection Market Value by Application: 2025 vs 2032
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Atropine Sulfate for Injection Market Size Estimates and Forecasts
1.4.1 Global Atropine Sulfate for Injection Revenue 2021–2032
1.4.2 Global Atropine Sulfate for Injection Sales 2021–2032
1.4.3 Global Atropine Sulfate for Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Atropine Sulfate for Injection Market Competition by Manufacturers
2.1 Global Atropine Sulfate for Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global Atropine Sulfate for Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Atropine Sulfate for Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Atropine Sulfate for Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Atropine Sulfate for Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Atropine Sulfate for Injection, Product Types and Applications
2.7 Global Key Manufacturers of Atropine Sulfate for Injection, Date of Entry into the Industry
2.8 Global Atropine Sulfate for Injection Market Competitive Situation and Trends
2.8.1 Global Atropine Sulfate for Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Atropine Sulfate for Injection Players Market Share by Revenue
2.8.3 Global Atropine Sulfate for Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atropine Sulfate for Injection Market Scenario by Region
3.1 Global Atropine Sulfate for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Atropine Sulfate for Injection Sales by Region: 2021–2032
3.2.1 Global Atropine Sulfate for Injection Sales by Region: 2021–2026
3.2.2 Global Atropine Sulfate for Injection Sales by Region: 2027–2032
3.3 Global Atropine Sulfate for Injection Revenue by Region: 2021–2032
3.3.1 Global Atropine Sulfate for Injection Revenue by Region: 2021–2026
3.3.2 Global Atropine Sulfate for Injection Revenue by Region: 2027–2032
3.4 North America Atropine Sulfate for Injection Market Facts & Figures by Country
3.4.1 North America Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Atropine Sulfate for Injection Sales by Country (2021–2032)
3.4.3 North America Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atropine Sulfate for Injection Market Facts & Figures by Country
3.5.1 Europe Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Atropine Sulfate for Injection Sales by Country (2021–2032)
3.5.3 Europe Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atropine Sulfate for Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Atropine Sulfate for Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Atropine Sulfate for Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific Atropine Sulfate for Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Atropine Sulfate for Injection Market Facts & Figures by Country
3.7.1 Latin America Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Atropine Sulfate for Injection Sales by Country (2021–2032)
3.7.3 Latin America Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Atropine Sulfate for Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Atropine Sulfate for Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Atropine Sulfate for Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa Atropine Sulfate for Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atropine Sulfate for Injection Sales by Type (2021–2032)
4.1.1 Global Atropine Sulfate for Injection Sales by Type (2021–2026)
4.1.2 Global Atropine Sulfate for Injection Sales by Type (2027–2032)
4.1.3 Global Atropine Sulfate for Injection Sales Market Share by Type (2021–2032)
4.2 Global Atropine Sulfate for Injection Revenue by Type (2021–2032)
4.2.1 Global Atropine Sulfate for Injection Revenue by Type (2021–2026)
4.2.2 Global Atropine Sulfate for Injection Revenue by Type (2027–2032)
4.2.3 Global Atropine Sulfate for Injection Revenue Market Share by Type (2021–2032)
4.3 Global Atropine Sulfate for Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global Atropine Sulfate for Injection Sales by Application (2021–2032)
5.1.1 Global Atropine Sulfate for Injection Sales by Application (2021–2026)
5.1.2 Global Atropine Sulfate for Injection Sales by Application (2027–2032)
5.1.3 Global Atropine Sulfate for Injection Sales Market Share by Application (2021–2032)
5.2 Global Atropine Sulfate for Injection Revenue by Application (2021–2032)
5.2.1 Global Atropine Sulfate for Injection Revenue by Application (2021–2026)
5.2.2 Global Atropine Sulfate for Injection Revenue by Application (2027–2032)
5.2.3 Global Atropine Sulfate for Injection Revenue Market Share by Application (2021–2032)
5.3 Global Atropine Sulfate for Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Atropine Sulfate for Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 American Regent
6.2.1 American Regent Company Information
6.2.2 American Regent Description and Business Overview
6.2.3 American Regent Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 American Regent Atropine Sulfate for Injection Product Portfolio
6.2.5 American Regent Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Company Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Hikma Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Company Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Apotex Atropine Sulfate for Injection Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Amneal Pharmaceuticals
6.5.1 Amneal Pharmaceuticals Company Information
6.5.2 Amneal Pharmaceuticals Description and Business Overview
6.5.3 Amneal Pharmaceuticals Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Amneal Pharmaceuticals Atropine Sulfate for Injection Product Portfolio
6.5.5 Amneal Pharmaceuticals Recent Developments/Updates
6.6 Accord Healthcare
6.6.1 Accord Healthcare Company Information
6.6.2 Accord Healthcare Description and Business Overview
6.6.3 Accord Healthcare Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Accord Healthcare Atropine Sulfate for Injection Product Portfolio
6.6.5 Accord Healthcare Recent Developments/Updates
6.7 China Res Double-Crane
6.7.1 China Res Double-Crane Company Information
6.7.2 China Res Double-Crane Description and Business Overview
6.7.3 China Res Double-Crane Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 China Res Double-Crane Atropine Sulfate for Injection Product Portfolio
6.7.5 China Res Double-Crane Recent Developments/Updates
6.8 Hebei Kaiwei Pharmaceutical
6.8.1 Hebei Kaiwei Pharmaceutical Company Information
6.8.2 Hebei Kaiwei Pharmaceutical Description and Business Overview
6.8.3 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.8.5 Hebei Kaiwei Pharmaceutical Recent Developments/Updates
6.9 Hebei Tiancheng Pharmaceutical
6.9.1 Hebei Tiancheng Pharmaceutical Company Information
6.9.2 Hebei Tiancheng Pharmaceutical Description and Business Overview
6.9.3 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.9.5 Hebei Tiancheng Pharmaceutical Recent Developments/Updates
6.10 Tai Yu Chemical & Pharmaceutical
6.10.1 Tai Yu Chemical & Pharmaceutical Company Information
6.10.2 Tai Yu Chemical & Pharmaceutical Description and Business Overview
6.10.3 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.10.5 Tai Yu Chemical & Pharmaceutical Recent Developments/Updates
6.11 Tianjin Jinyao Pharmaceutical
6.11.1 Tianjin Jinyao Pharmaceutical Company Information
6.11.2 Tianjin Jinyao Pharmaceutical Description and Business Overview
6.11.3 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.11.5 Tianjin Jinyao Pharmaceutical Recent Developments/Updates
6.12 Sunflower Pharmaceutical
6.12.1 Sunflower Pharmaceutical Company Information
6.12.2 Sunflower Pharmaceutical Description and Business Overview
6.12.3 Sunflower Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sunflower Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.12.5 Sunflower Pharmaceutical Recent Developments/Updates
6.13 China Shineway Pharm
6.13.1 China Shineway Pharm Company Information
6.13.2 China Shineway Pharm Description and Business Overview
6.13.3 China Shineway Pharm Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 China Shineway Pharm Atropine Sulfate for Injection Product Portfolio
6.13.5 China Shineway Pharm Recent Developments/Updates
6.14 CSPC Ouyi Pharmaceutical
6.14.1 CSPC Ouyi Pharmaceutical Company Information
6.14.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.14.3 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.14.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.15 Suicheng Pharmaceutical
6.15.1 Suicheng Pharmaceutical Company Information
6.15.2 Suicheng Pharmaceutical Description and Business Overview
6.15.3 Suicheng Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Suicheng Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.15.5 Suicheng Pharmaceutical Recent Developments/Updates
6.16 Chengdu Brilliant Pharmaceutical
6.16.1 Chengdu Brilliant Pharmaceutical Company Information
6.16.2 Chengdu Brilliant Pharmaceutical Description and Business Overview
6.16.3 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.16.5 Chengdu Brilliant Pharmaceutical Recent Developments/Updates
6.17 Anhui Changjiang Pharmaceutical
6.17.1 Anhui Changjiang Pharmaceutical Company Information
6.17.2 Anhui Changjiang Pharmaceutical Description and Business Overview
6.17.3 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.17.5 Anhui Changjiang Pharmaceutical Recent Developments/Updates
6.18 Shanghai Harvest Pharmaceutical
6.18.1 Shanghai Harvest Pharmaceutical Company Information
6.18.2 Shanghai Harvest Pharmaceutical Description and Business Overview
6.18.3 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.18.5 Shanghai Harvest Pharmaceutical Recent Developments/Updates
6.19 Hubei Xinghua Pharmaceutical
6.19.1 Hubei Xinghua Pharmaceutical Company Information
6.19.2 Hubei Xinghua Pharmaceutical Description and Business Overview
6.19.3 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Product Portfolio
6.19.5 Hubei Xinghua Pharmaceutical Recent Developments/Updates
6.20 Changzhou Pharmaceutical Factory
6.20.1 Changzhou Pharmaceutical Factory Company Information
6.20.2 Changzhou Pharmaceutical Factory Description and Business Overview
6.20.3 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Product Portfolio
6.20.5 Changzhou Pharmaceutical Factory Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atropine Sulfate for Injection Industry Chain Analysis
7.2 Atropine Sulfate for Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atropine Sulfate for Injection Production Mode & Process Analysis
7.4 Atropine Sulfate for Injection Sales and Marketing
7.4.1 Atropine Sulfate for Injection Sales Channels
7.4.2 Atropine Sulfate for Injection Distributors
7.5 Atropine Sulfate for Injection Customer Analysis
8 Atropine Sulfate for Injection Market Dynamics
8.1 Atropine Sulfate for Injection Industry Trends
8.2 Atropine Sulfate for Injection Market Drivers
8.3 Atropine Sulfate for Injection Market Challenges
8.4 Atropine Sulfate for Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Atropine Sulfate for Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Atropine Sulfate for Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Atropine Sulfate for Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Atropine Sulfate for Injection Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Atropine Sulfate for Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Atropine Sulfate for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Atropine Sulfate for Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Atropine Sulfate for Injection Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Atropine Sulfate for Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Atropine Sulfate for Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Atropine Sulfate for Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Atropine Sulfate for Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Atropine Sulfate for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Atropine Sulfate for Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Atropine Sulfate for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Atropine Sulfate for Injection Sales by Region (K Dose), 2021–2026
Table 18. Global Atropine Sulfate for Injection Sales Market Share by Region (2021–2026)
Table 19. Global Atropine Sulfate for Injection Sales by Region (K Dose), 2027–2032
Table 20. Global Atropine Sulfate for Injection Sales Market Share by Region (2027–2032)
Table 21. Global Atropine Sulfate for Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Atropine Sulfate for Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Atropine Sulfate for Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Atropine Sulfate for Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
Table 27. North America Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
Table 28. North America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
Table 32. Europe Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
Table 33. Europe Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Atropine Sulfate for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Atropine Sulfate for Injection Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Atropine Sulfate for Injection Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Atropine Sulfate for Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Atropine Sulfate for Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
Table 42. Latin America Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
Table 43. Latin America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Atropine Sulfate for Injection Sales (K Dose) by Type (2021–2026)
Table 51. Global Atropine Sulfate for Injection Sales (K Dose) by Type (2027–2032)
Table 52. Global Atropine Sulfate for Injection Sales Market Share by Type (2021–2026)
Table 53. Global Atropine Sulfate for Injection Sales Market Share by Type (2027–2032)
Table 54. Global Atropine Sulfate for Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Atropine Sulfate for Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Atropine Sulfate for Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Atropine Sulfate for Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Atropine Sulfate for Injection Price (US$/Dose) by Type (2021–2026)
Table 59. Global Atropine Sulfate for Injection Price (US$/Dose) by Type (2027–2032)
Table 60. Global Atropine Sulfate for Injection Sales (K Dose) by Application (2021–2026)
Table 61. Global Atropine Sulfate for Injection Sales (K Dose) by Application (2027–2032)
Table 62. Global Atropine Sulfate for Injection Sales Market Share by Application (2021–2026)
Table 63. Global Atropine Sulfate for Injection Sales Market Share by Application (2027–2032)
Table 64. Global Atropine Sulfate for Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Atropine Sulfate for Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Atropine Sulfate for Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Atropine Sulfate for Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Atropine Sulfate for Injection Price (US$/Dose) by Application (2021–2026)
Table 69. Global Atropine Sulfate for Injection Price (US$/Dose) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Pfizer Atropine Sulfate for Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. American Regent Company Information
Table 76. American Regent Description and Business Overview
Table 77. American Regent Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. American Regent Atropine Sulfate for Injection Product
Table 79. American Regent Recent Developments/Updates
Table 80. Hikma Pharmaceuticals Company Information
Table 81. Hikma Pharmaceuticals Description and Business Overview
Table 82. Hikma Pharmaceuticals Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Hikma Pharmaceuticals Atropine Sulfate for Injection Product
Table 84. Hikma Pharmaceuticals Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Apotex Atropine Sulfate for Injection Product
Table 89. Apotex Recent Developments/Updates
Table 90. Amneal Pharmaceuticals Company Information
Table 91. Amneal Pharmaceuticals Description and Business Overview
Table 92. Amneal Pharmaceuticals Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Amneal Pharmaceuticals Atropine Sulfate for Injection Product
Table 94. Amneal Pharmaceuticals Recent Developments/Updates
Table 95. Accord Healthcare Company Information
Table 96. Accord Healthcare Description and Business Overview
Table 97. Accord Healthcare Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Accord Healthcare Atropine Sulfate for Injection Product
Table 99. Accord Healthcare Recent Developments/Updates
Table 100. China Res Double-Crane Company Information
Table 101. China Res Double-Crane Description and Business Overview
Table 102. China Res Double-Crane Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. China Res Double-Crane Atropine Sulfate for Injection Product
Table 104. China Res Double-Crane Recent Developments/Updates
Table 105. Hebei Kaiwei Pharmaceutical Company Information
Table 106. Hebei Kaiwei Pharmaceutical Description and Business Overview
Table 107. Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Product
Table 109. Hebei Kaiwei Pharmaceutical Recent Developments/Updates
Table 110. Hebei Tiancheng Pharmaceutical Company Information
Table 111. Hebei Tiancheng Pharmaceutical Description and Business Overview
Table 112. Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Product
Table 114. Hebei Tiancheng Pharmaceutical Recent Developments/Updates
Table 115. Tai Yu Chemical & Pharmaceutical Company Information
Table 116. Tai Yu Chemical & Pharmaceutical Description and Business Overview
Table 117. Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Product
Table 119. Tai Yu Chemical & Pharmaceutical Recent Developments/Updates
Table 120. Tianjin Jinyao Pharmaceutical Company Information
Table 121. Tianjin Jinyao Pharmaceutical Description and Business Overview
Table 122. Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Product
Table 124. Tianjin Jinyao Pharmaceutical Recent Developments/Updates
Table 125. Sunflower Pharmaceutical Company Information
Table 126. Sunflower Pharmaceutical Description and Business Overview
Table 127. Sunflower Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 128. Sunflower Pharmaceutical Atropine Sulfate for Injection Product
Table 129. Sunflower Pharmaceutical Recent Developments/Updates
Table 130. China Shineway Pharm Company Information
Table 131. China Shineway Pharm Description and Business Overview
Table 132. China Shineway Pharm Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 133. China Shineway Pharm Atropine Sulfate for Injection Product
Table 134. China Shineway Pharm Recent Developments/Updates
Table 135. CSPC Ouyi Pharmaceutical Company Information
Table 136. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 137. CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 138. CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Product
Table 139. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 140. Suicheng Pharmaceutical Company Information
Table 141. Suicheng Pharmaceutical Description and Business Overview
Table 142. Suicheng Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 143. Suicheng Pharmaceutical Atropine Sulfate for Injection Product
Table 144. Suicheng Pharmaceutical Recent Developments/Updates
Table 145. Chengdu Brilliant Pharmaceutical Company Information
Table 146. Chengdu Brilliant Pharmaceutical Description and Business Overview
Table 147. Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 148. Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Product
Table 149. Chengdu Brilliant Pharmaceutical Recent Developments/Updates
Table 150. Anhui Changjiang Pharmaceutical Company Information
Table 151. Anhui Changjiang Pharmaceutical Description and Business Overview
Table 152. Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 153. Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Product
Table 154. Anhui Changjiang Pharmaceutical Recent Developments/Updates
Table 155. Shanghai Harvest Pharmaceutical Company Information
Table 156. Shanghai Harvest Pharmaceutical Description and Business Overview
Table 157. Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 158. Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Product
Table 159. Shanghai Harvest Pharmaceutical Recent Developments/Updates
Table 160. Hubei Xinghua Pharmaceutical Company Information
Table 161. Hubei Xinghua Pharmaceutical Description and Business Overview
Table 162. Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 163. Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Product
Table 164. Hubei Xinghua Pharmaceutical Recent Developments/Updates
Table 165. Changzhou Pharmaceutical Factory Company Information
Table 166. Changzhou Pharmaceutical Factory Description and Business Overview
Table 167. Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 168. Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Product
Table 169. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Atropine Sulfate for Injection Distributors List
Table 173. Atropine Sulfate for Injection Customers List
Table 174. Atropine Sulfate for Injection Market Trends
Table 175. Atropine Sulfate for Injection Market Drivers
Table 176. Atropine Sulfate for Injection Market Challenges
Table 177. Atropine Sulfate for Injection Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Atropine Sulfate for Injection
Figure 2. Global Atropine Sulfate for Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Atropine Sulfate for Injection Market Share by Type: 2025 & 2032
Figure 4. 0.5 mg/mL Product Picture
Figure 5. 1 mg/mL Product Picture
Figure 6. 5 mg/ml Product Picture
Figure 7. Others Product Picture
Figure 8. Global Atropine Sulfate for Injection Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Atropine Sulfate for Injection Market Share by Application: 2025 & 2032
Figure 10. Online Sales
Figure 11. Offline Sales
Figure 12. Global Atropine Sulfate for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Atropine Sulfate for Injection Market Size (US$ Million), 2021–2032
Figure 14. Global Atropine Sulfate for Injection Sales (K Dose), 2021–2032
Figure 15. Global Atropine Sulfate for Injection Average Price (US$/Dose), 2021–2032
Figure 16. Atropine Sulfate for Injection Report Years Considered
Figure 17. Atropine Sulfate for Injection Sales Share by Manufacturers in 2025
Figure 18. Global Atropine Sulfate for Injection Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Atropine Sulfate for Injection Players: Market Share by Revenue in Atropine Sulfate for Injection in 2025
Figure 20. Atropine Sulfate for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Atropine Sulfate for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
Figure 23. North America Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
Figure 24. United States Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
Figure 27. Europe Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
Figure 28. Germany Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Atropine Sulfate for Injection Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Atropine Sulfate for Injection Revenue Market Share by Region (2021–2032)
Figure 35. China Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
Figure 43. Latin America Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Atropine Sulfate for Injection by Type (2021–2032)
Figure 54. Global Revenue Market Share of Atropine Sulfate for Injection by Type (2021–2032)
Figure 55. Global Atropine Sulfate for Injection Price (US$/Dose) by Type (2021–2032)
Figure 56. Global Sales Market Share of Atropine Sulfate for Injection by Application (2021–2032)
Figure 57. Global Revenue Market Share of Atropine Sulfate for Injection by Application (2021–2032)
Figure 58. Global Atropine Sulfate for Injection Price (US$/Dose) by Application (2021–2032)
Figure 59. Atropine Sulfate for Injection Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Atropine Sulfate for Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Atropine Sulfate for Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Atropine Sulfate for Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Atropine Sulfate for Injection Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Atropine Sulfate for Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Atropine Sulfate for Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Atropine Sulfate for Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Atropine Sulfate for Injection Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Atropine Sulfate for Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Atropine Sulfate for Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Atropine Sulfate for Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Atropine Sulfate for Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Atropine Sulfate for Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Atropine Sulfate for Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Atropine Sulfate for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Atropine Sulfate for Injection Sales by Region (K Dose), 2021–2026
Table 18. Global Atropine Sulfate for Injection Sales Market Share by Region (2021–2026)
Table 19. Global Atropine Sulfate for Injection Sales by Region (K Dose), 2027–2032
Table 20. Global Atropine Sulfate for Injection Sales Market Share by Region (2027–2032)
Table 21. Global Atropine Sulfate for Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Atropine Sulfate for Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Atropine Sulfate for Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Atropine Sulfate for Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
Table 27. North America Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
Table 28. North America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
Table 32. Europe Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
Table 33. Europe Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Atropine Sulfate for Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Atropine Sulfate for Injection Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Atropine Sulfate for Injection Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Atropine Sulfate for Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Atropine Sulfate for Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
Table 42. Latin America Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
Table 43. Latin America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Atropine Sulfate for Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Atropine Sulfate for Injection Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Atropine Sulfate for Injection Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Atropine Sulfate for Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Atropine Sulfate for Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Atropine Sulfate for Injection Sales (K Dose) by Type (2021–2026)
Table 51. Global Atropine Sulfate for Injection Sales (K Dose) by Type (2027–2032)
Table 52. Global Atropine Sulfate for Injection Sales Market Share by Type (2021–2026)
Table 53. Global Atropine Sulfate for Injection Sales Market Share by Type (2027–2032)
Table 54. Global Atropine Sulfate for Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Atropine Sulfate for Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Atropine Sulfate for Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Atropine Sulfate for Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Atropine Sulfate for Injection Price (US$/Dose) by Type (2021–2026)
Table 59. Global Atropine Sulfate for Injection Price (US$/Dose) by Type (2027–2032)
Table 60. Global Atropine Sulfate for Injection Sales (K Dose) by Application (2021–2026)
Table 61. Global Atropine Sulfate for Injection Sales (K Dose) by Application (2027–2032)
Table 62. Global Atropine Sulfate for Injection Sales Market Share by Application (2021–2026)
Table 63. Global Atropine Sulfate for Injection Sales Market Share by Application (2027–2032)
Table 64. Global Atropine Sulfate for Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Atropine Sulfate for Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Atropine Sulfate for Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Atropine Sulfate for Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Atropine Sulfate for Injection Price (US$/Dose) by Application (2021–2026)
Table 69. Global Atropine Sulfate for Injection Price (US$/Dose) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Pfizer Atropine Sulfate for Injection Product
Table 74. Pfizer Recent Developments/Updates
Table 75. American Regent Company Information
Table 76. American Regent Description and Business Overview
Table 77. American Regent Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. American Regent Atropine Sulfate for Injection Product
Table 79. American Regent Recent Developments/Updates
Table 80. Hikma Pharmaceuticals Company Information
Table 81. Hikma Pharmaceuticals Description and Business Overview
Table 82. Hikma Pharmaceuticals Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Hikma Pharmaceuticals Atropine Sulfate for Injection Product
Table 84. Hikma Pharmaceuticals Recent Developments/Updates
Table 85. Apotex Company Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Apotex Atropine Sulfate for Injection Product
Table 89. Apotex Recent Developments/Updates
Table 90. Amneal Pharmaceuticals Company Information
Table 91. Amneal Pharmaceuticals Description and Business Overview
Table 92. Amneal Pharmaceuticals Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Amneal Pharmaceuticals Atropine Sulfate for Injection Product
Table 94. Amneal Pharmaceuticals Recent Developments/Updates
Table 95. Accord Healthcare Company Information
Table 96. Accord Healthcare Description and Business Overview
Table 97. Accord Healthcare Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. Accord Healthcare Atropine Sulfate for Injection Product
Table 99. Accord Healthcare Recent Developments/Updates
Table 100. China Res Double-Crane Company Information
Table 101. China Res Double-Crane Description and Business Overview
Table 102. China Res Double-Crane Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. China Res Double-Crane Atropine Sulfate for Injection Product
Table 104. China Res Double-Crane Recent Developments/Updates
Table 105. Hebei Kaiwei Pharmaceutical Company Information
Table 106. Hebei Kaiwei Pharmaceutical Description and Business Overview
Table 107. Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Hebei Kaiwei Pharmaceutical Atropine Sulfate for Injection Product
Table 109. Hebei Kaiwei Pharmaceutical Recent Developments/Updates
Table 110. Hebei Tiancheng Pharmaceutical Company Information
Table 111. Hebei Tiancheng Pharmaceutical Description and Business Overview
Table 112. Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Hebei Tiancheng Pharmaceutical Atropine Sulfate for Injection Product
Table 114. Hebei Tiancheng Pharmaceutical Recent Developments/Updates
Table 115. Tai Yu Chemical & Pharmaceutical Company Information
Table 116. Tai Yu Chemical & Pharmaceutical Description and Business Overview
Table 117. Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Tai Yu Chemical & Pharmaceutical Atropine Sulfate for Injection Product
Table 119. Tai Yu Chemical & Pharmaceutical Recent Developments/Updates
Table 120. Tianjin Jinyao Pharmaceutical Company Information
Table 121. Tianjin Jinyao Pharmaceutical Description and Business Overview
Table 122. Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. Tianjin Jinyao Pharmaceutical Atropine Sulfate for Injection Product
Table 124. Tianjin Jinyao Pharmaceutical Recent Developments/Updates
Table 125. Sunflower Pharmaceutical Company Information
Table 126. Sunflower Pharmaceutical Description and Business Overview
Table 127. Sunflower Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 128. Sunflower Pharmaceutical Atropine Sulfate for Injection Product
Table 129. Sunflower Pharmaceutical Recent Developments/Updates
Table 130. China Shineway Pharm Company Information
Table 131. China Shineway Pharm Description and Business Overview
Table 132. China Shineway Pharm Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 133. China Shineway Pharm Atropine Sulfate for Injection Product
Table 134. China Shineway Pharm Recent Developments/Updates
Table 135. CSPC Ouyi Pharmaceutical Company Information
Table 136. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 137. CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 138. CSPC Ouyi Pharmaceutical Atropine Sulfate for Injection Product
Table 139. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 140. Suicheng Pharmaceutical Company Information
Table 141. Suicheng Pharmaceutical Description and Business Overview
Table 142. Suicheng Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 143. Suicheng Pharmaceutical Atropine Sulfate for Injection Product
Table 144. Suicheng Pharmaceutical Recent Developments/Updates
Table 145. Chengdu Brilliant Pharmaceutical Company Information
Table 146. Chengdu Brilliant Pharmaceutical Description and Business Overview
Table 147. Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 148. Chengdu Brilliant Pharmaceutical Atropine Sulfate for Injection Product
Table 149. Chengdu Brilliant Pharmaceutical Recent Developments/Updates
Table 150. Anhui Changjiang Pharmaceutical Company Information
Table 151. Anhui Changjiang Pharmaceutical Description and Business Overview
Table 152. Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 153. Anhui Changjiang Pharmaceutical Atropine Sulfate for Injection Product
Table 154. Anhui Changjiang Pharmaceutical Recent Developments/Updates
Table 155. Shanghai Harvest Pharmaceutical Company Information
Table 156. Shanghai Harvest Pharmaceutical Description and Business Overview
Table 157. Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 158. Shanghai Harvest Pharmaceutical Atropine Sulfate for Injection Product
Table 159. Shanghai Harvest Pharmaceutical Recent Developments/Updates
Table 160. Hubei Xinghua Pharmaceutical Company Information
Table 161. Hubei Xinghua Pharmaceutical Description and Business Overview
Table 162. Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 163. Hubei Xinghua Pharmaceutical Atropine Sulfate for Injection Product
Table 164. Hubei Xinghua Pharmaceutical Recent Developments/Updates
Table 165. Changzhou Pharmaceutical Factory Company Information
Table 166. Changzhou Pharmaceutical Factory Description and Business Overview
Table 167. Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 168. Changzhou Pharmaceutical Factory Atropine Sulfate for Injection Product
Table 169. Changzhou Pharmaceutical Factory Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Atropine Sulfate for Injection Distributors List
Table 173. Atropine Sulfate for Injection Customers List
Table 174. Atropine Sulfate for Injection Market Trends
Table 175. Atropine Sulfate for Injection Market Drivers
Table 176. Atropine Sulfate for Injection Market Challenges
Table 177. Atropine Sulfate for Injection Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Atropine Sulfate for Injection
Figure 2. Global Atropine Sulfate for Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Atropine Sulfate for Injection Market Share by Type: 2025 & 2032
Figure 4. 0.5 mg/mL Product Picture
Figure 5. 1 mg/mL Product Picture
Figure 6. 5 mg/ml Product Picture
Figure 7. Others Product Picture
Figure 8. Global Atropine Sulfate for Injection Market Value by Application (US$ Million), 2021–2032
Figure 9. Global Atropine Sulfate for Injection Market Share by Application: 2025 & 2032
Figure 10. Online Sales
Figure 11. Offline Sales
Figure 12. Global Atropine Sulfate for Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Atropine Sulfate for Injection Market Size (US$ Million), 2021–2032
Figure 14. Global Atropine Sulfate for Injection Sales (K Dose), 2021–2032
Figure 15. Global Atropine Sulfate for Injection Average Price (US$/Dose), 2021–2032
Figure 16. Atropine Sulfate for Injection Report Years Considered
Figure 17. Atropine Sulfate for Injection Sales Share by Manufacturers in 2025
Figure 18. Global Atropine Sulfate for Injection Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Atropine Sulfate for Injection Players: Market Share by Revenue in Atropine Sulfate for Injection in 2025
Figure 20. Atropine Sulfate for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Atropine Sulfate for Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
Figure 23. North America Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
Figure 24. United States Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
Figure 27. Europe Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
Figure 28. Germany Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Atropine Sulfate for Injection Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Atropine Sulfate for Injection Revenue Market Share by Region (2021–2032)
Figure 35. China Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
Figure 43. Latin America Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Atropine Sulfate for Injection Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Atropine Sulfate for Injection Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Atropine Sulfate for Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Atropine Sulfate for Injection by Type (2021–2032)
Figure 54. Global Revenue Market Share of Atropine Sulfate for Injection by Type (2021–2032)
Figure 55. Global Atropine Sulfate for Injection Price (US$/Dose) by Type (2021–2032)
Figure 56. Global Sales Market Share of Atropine Sulfate for Injection by Application (2021–2032)
Figure 57. Global Revenue Market Share of Atropine Sulfate for Injection by Application (2021–2032)
Figure 58. Global Atropine Sulfate for Injection Price (US$/Dose) by Application (2021–2032)
Figure 59. Atropine Sulfate for Injection Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Sales Planning Tool Market Research Report 2026
Feb 03, 26
Global Chromium Oxide Powder Market Research Report 2026
Feb 03, 26
Global Shape Memory Actuator Market Research Report 2026
Feb 03, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232